NovaBay Pharmaceuticals Submits Matters to Security Holders
Ticker: NBY · Form: 8-K · Filed: Apr 22, 2025 · CIK: 1389545
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: NBY
TL;DR
NovaBay had a shareholder vote on April 16th. Details TBD.
AI Summary
NovaBay Pharmaceuticals, Inc. filed an 8-K on April 22, 2025, reporting that on April 16, 2025, matters were submitted to a vote of its security holders. The filing does not disclose the specific matters voted upon or the outcome of the vote.
Why It Matters
This filing indicates a shareholder vote occurred, which could signal significant corporate actions or changes requiring shareholder approval.
Risk Assessment
Risk Level: medium — The filing is a procedural update about a shareholder vote, but the lack of detail on the matters voted upon introduces uncertainty.
Key Players & Entities
- NovaBay Pharmaceuticals, Inc. (company) — Registrant
- April 16, 2025 (date) — Date of earliest event reported
- April 22, 2025 (date) — Filing date
FAQ
What specific matters were submitted for a vote by NovaBay Pharmaceuticals' security holders on April 16, 2025?
The filing does not specify the exact matters submitted for a vote.
What was the outcome of the vote by NovaBay Pharmaceuticals' security holders on April 16, 2025?
The filing does not disclose the results or outcome of the shareholder vote.
Is this 8-K filing related to a specific corporate event or transaction?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not provide details on the underlying event.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 16, 2025.
What is the principal executive office address for NovaBay Pharmaceuticals, Inc.?
The address is 2000 Powell Street, Suite 1150, Emeryville, CA 94608.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding NovaBay Pharmaceuticals, Inc. (NBY).